Information for the public
About rituximab
About rituximab
Rituximab is a medicine known as a 'monoclonal antibody'.
It is licensed for treating various conditions in adults (aged 18 years and over) including non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, and granulomatosis with polyangiitis, or microscopic polyangiitis. It is not licensed for use in children. Rituximab is given by a drip (also known as an infusion) into a vein. This would usually be carried out in hospital by a doctor or nurse who has experience in using the treatment.
Rituximab is not licensed for treating ITP in children or adults, and so using it for ITP is 'off‑label'.